PTCL, NOS: An update on classification, risk-stratification, and treatment [PDF]
Frontiers in Oncology, 2023 The peripheral T-cell lymphomas (PTCL) are relatively rare, heterogeneous, and therapeutically challenging. While significant therapeutic gains and improved understanding of disease pathogenesis have been realized for selected PTCL subtypes, the most ...
Jonathan Weis +2 more
exaly +4 more sources
Phosphorylated STAT3 as a potential diagnostic and predictive biomarker in ALK- ALCL vs. CD30high PTCL, NOS [PDF]
Frontiers in Immunology, 2023 AimsThe differential diagnosis between ALK-negative anaplastic large cell lymphoma (ALK- ALCL) and peripheral T-cell lymphoma, not otherwise specified (PTCL, NOS) with high expression of CD30 (CD30high) are essential.
Cuiling Liu +2 more
exaly +4 more sources
Burrowing through the Heterogeneity: Review of Mouse Models of PTCL-NOS [PDF]
Frontiers in Oncology, 2016 Currently, there are nineteen different PTCL entities recognized by the World Health Organization; however, approximately 70 percent of PTCL diagnoses fall within one of three subtypes (i.e.
Christine E Cutucache +1 more
exaly +4 more sources
ENO1 inhibition synergizes with chidamide to induce ferroptosis in PTCL-NOS through metabolic remodeling [PDF]
Blood ScienceEnolase (ENO1) is a key enzyme involved in glycolysis and plays an important role in various types of cancer. This study explored the role and mechanism of ENO1 and the histone deacetylase inhibitor chidamide in peripheral T cell lymphoma, not otherwise ...
Feng Zhu +12 more
doaj +2 more sources
Cardiac involvement as first manifestation of peripheral T-cell not otherwise specified lymphoma [PDF]
European Journal of Case Reports in Internal MedicineCardiac involvement as the first manifestation of peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) is extremely rare. We report on a 72-year-old man with hypertension, dyslipidaemia and prediabetes who presented with acute pleuropericarditis,
Paula Awamleh García +6 more
doaj +2 more sources
Clinicopathological comparison between PTCL‐TBX21 and PTCL‐GATA3 in Japanese patients
Cancer MedicineAim Peripheral T‐cell lymphoma not otherwise specified (PTCL‐NOS) is a heterogeneous disease that can be classified into the PTCL‐TBX21 and PTCL‐GATA3 subtypes. Methods In this study, we compared the clinicopathological features of PTCL‐NOS in a Japanese
Yasumasa Shimasaki +2 more
exaly +2 more sources
Molecular understanding of peripheral T-cell lymphomas, not otherwise specified (PTCL, NOS): A complex disease category [PDF]
Journal of Clinical and Experimental Hematopathology: JCEH, 2021 Mamiko Sakata-Yanagimoto +2 more
exaly +2 more sources
Peripheral T cell lymphoma not otherwise specified (PTCL-NOS) presenting as an endobronchial lesion: Case report and literature review [PDF]
Respiratory Medicine Case Reports, 2018 Peripheral T cell lymphoma not otherwise specified (PTCL-NOS) is a rare entity of lymphoma. We herein report an even rarer case of a 68-year-old male with PTCL-NOS presenting as an endobronchial lesion, and review previously published cases in the ...
Takuto Sueyasu +13 more
doaj +2 more sources
Lymphoma Microenvironment in DLBCL and PTCL-NOS: the key to uncovering heterogeneity and the potential for stratification [PDF]
Journal of Clinical and Experimental Hematopathology: JCEH, 2022 Kohta Miyawaki, Takeshi Sugio
exaly +2 more sources
The role of pre-treatment and mid-treatment 18F-FDG PET/CT imaging in evaluating prognosis of peripheral T-cell lymphoma-not otherwise specified (PTCL-NOS) [PDF]
BMC Medical Imaging, 2021 Yafei Zhang, Guangfa Wang, Xin Zhao
exaly +2 more sources